How to use Technology Offers
The `Technologies offered´-section displays product and technology opportunities. Text search allows the use of phrases not yet part of the category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in `Sector´, "Cancerous, neoplasmatic" in `Disease Category, "Drugs, Small Molecule" in `Technology´ and "Preclinical" in `Development Stage´.
Selection of "Enabling Technology, Platform Technology" in `Sector´ will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.
Registered users can create non-public notifications profiles which will inform them about new Technology Offered entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.
700 results found
Displaying results 1 to 20 out of 700
- C3a-Receptor monoclonal antibodies from University of Goettingen
C3a are known to trigger mast cell degranulation (Anaphylatoxin)
- Means and Methods for Treating Peripheral and Cardiovascular Diseases via Modulation of Arteriogenesis offered by Max-Planck-Innovation
Trpv4 is highly suitable for the development of new therapeutic concepts in order to cure peripheral and cardiovascular diseases
- Genentech is interested in a broad range of therapeutic candidates and enabling technologies
- Sanofi Pasteur is seeking opportunities in vaccines, antibodies and supporting technologies for prevention of treatment of infectious diseases
novel antigens, carrier proteins, adjuvants, vaccine vectors, basic immunology, fermentor and bioreactor technology, preservatives and stabilizers, biological markers, epidemiological studies
- Decellularized Adipose Tissue for Soft Tissue Augmentation
method of producing an intact, adipose tissue-derived extracellular matrix devoid of cells
© 2006-2007
by Herbert-Worch-Foundation